A Simple 30-Minute Test Strip for Detecting the Heart Failure Biomarker BNP Without Lab Equipment
Engineers created a rapid, equipment-free test strip that detects the heart failure peptide biomarker BNP at clinically useful levels in 30 minutes at room temperature.
Quick Facts
What This Study Found
Researchers developed a new lateral flow test that detects brain natriuretic peptide (BNP) at clinically relevant levels (100 pg/mL threshold) in just 30 minutes at room temperature without requiring enzymes, cold storage, or laboratory equipment. The system uses two aptamers that simultaneously bind BNP, triggering an enzyme-free DNA amplification cascade that produces a visual result on a simple test strip.
Key Numbers
Clinical rule-out threshold: 100 pg/mL (0.03 nM) · Detection time: 30 minutes · Room temperature operation · Enzyme-free amplification · Dual-aptamer system
How They Did This
Proof-of-concept laboratory study developing a lateral flow biosensor. Designed a dual-aptamer system where two DNA aptamers bind BNP simultaneously, releasing complementary DNA strands that trigger cyclic isothermal amplification. The amplified DNA products are detected on a lateral flow test strip providing visual readout. Tested with spiked samples at room temperature.
Why This Research Matters
BNP is the key blood biomarker for diagnosing heart failure, but current tests require expensive lab equipment and cold-stored antibodies. A rapid, room-temperature test strip could bring heart failure diagnosis to emergency rooms, ambulances, and clinics in resource-limited settings where lab-based immunoassays aren't available.
The Bigger Picture
Point-of-care diagnostics are transforming how peptide biomarkers are used in medicine. BNP testing is critical for heart failure management, but access barriers in low-resource settings mean many patients go undiagnosed. This work represents a broader trend of replacing expensive antibody-based tests with aptamer technology — synthetic DNA molecules that can bind specific targets with antibody-like precision but without needing refrigeration. If validated clinically, this could democratize heart failure diagnosis globally.
What This Study Doesn't Tell Us
Proof-of-concept stage only — not yet validated with real human blood samples. Performance in clinical settings with complex biological matrices (blood, serum) is unknown. No comparison with existing commercial BNP immunoassays. Manufacturing scalability and cost not addressed. Interference from other blood components needs testing.
Questions This Raises
- ?Will this test maintain its sensitivity and specificity when used with actual patient blood samples?
- ?How does the cost of manufacturing this aptamer-based test compare to existing antibody-based BNP immunoassays?
- ?Could the same dual-aptamer lateral flow approach be adapted for other peptide biomarkers like NT-proBNP or troponin?
Trust & Context
- Key Stat:
- 30 minutes at room temperature Time to detect BNP at clinically relevant levels without enzymes or lab equipment
- Evidence Grade:
- Preliminary evidence: proof-of-concept laboratory study demonstrating technical feasibility. Not yet validated with human clinical samples, so clinical utility remains unproven.
- Study Age:
- Published in 2026. Cutting-edge technology development. Clinical validation studies are planned but not yet completed.
- Original Title:
- Lateral flow biosensors for low abundance detection of brain natriuretic peptide with enzyme-free amplification.
- Published In:
- Lab on a chip, 26(3), 627-634 (2026)
- Authors:
- Zhang, Menghan(2), Xu, Tao(3), Jajesniak, Pawel, Core, Giulia, Zeng, Zhuoer, Shalaby, Maha Mansour Mohamed, Reboud, Julien, Cooper, Jonathan M
- Database ID:
- RPEP-16554
Evidence Hierarchy
Frequently Asked Questions
What is BNP and why is it important for heart failure?
Brain natriuretic peptide (BNP) is released by heart muscle cells when the heart is under stress. Elevated BNP levels in the blood are one of the most reliable indicators of heart failure, and doctors routinely use BNP tests to diagnose the condition and guide treatment decisions.
How is this test different from existing BNP tests?
Current BNP tests use antibodies that need refrigeration and laboratory analyzers that cost thousands of dollars. This new test uses synthetic DNA aptamers instead of antibodies, works at room temperature, requires no equipment, and gives a visual result in 30 minutes — like a home pregnancy test but for heart failure.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-16554APA
Zhang, Menghan; Xu, Tao; Jajesniak, Pawel; Core, Giulia; Zeng, Zhuoer; Shalaby, Maha Mansour Mohamed; Reboud, Julien; Cooper, Jonathan M. (2026). Lateral flow biosensors for low abundance detection of brain natriuretic peptide with enzyme-free amplification.. Lab on a chip, 26(3), 627-634. https://doi.org/10.1039/d5lc00793c
MLA
Zhang, Menghan, et al. "Lateral flow biosensors for low abundance detection of brain natriuretic peptide with enzyme-free amplification.." Lab on a chip, 2026. https://doi.org/10.1039/d5lc00793c
RethinkPeptides
RethinkPeptides Research Database. "Lateral flow biosensors for low abundance detection of brain..." RPEP-16554. Retrieved from https://rethinkpeptides.com/research/zhang-2026-lateral-flow-biosensors-for
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.